T细胞凋亡在肿瘤免疫逃避中的作用
被引量:2
The role of T cell apoptosis in tumor immune evasion
摘要
肿瘤细胞通过多种途径引起肿瘤反应性T细胞凋亡是肿瘤实现免疫逃避的重要机制之一 ,现总结肿瘤免疫中T细胞凋亡的证据。
出处
《国外医学(肿瘤学分册)》
2003年第3期174-176,共3页
Foreign Medical Sciences (Cancer Section)
参考文献13
-
1Saito T, Dworacki G, (Gooding W, et al. Spontaneous apoptosis of CD8^+ T lymphocytes in peripheral blood of patients with advanced melanoma[J]. Clin Cancer Res,2000, 6(4) : 1351-1364.
-
2Banat GA, Christ O, Cochlovirus B, et al. Tumor-induced suppression of immune response and its correction[J].Cancer Immunol Immunother, 2001, 49( 11 ) : 573-586.
-
3Gastman BR,Johnson DE, Whiteside TL, et al. Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events[J]. Blood, 2000,95 (6) :2015-2023.
-
4Wischhusen J, Jung G, Radovanovic I, et al. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma[J ]. Cancer Res, 2002, 62(9) : 2592-2599.
-
5Koyanma S, Koike N, Adachi S. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric eanrcinoma[J]. Cancer Res Clin Oncol, 2001, 127(1): 20-26.
-
6Favre Felix N, Fromenatin A, Hammann A, et al. Cutting edge. the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway[J]. J Immunol,2000, 164(10) : 5023-5027.
-
7French LE, Tschopp J. Defective death receptor signaling as a cause of tumor immune escape[J]. Semin Cancer Biol, 2002, 12(1): 51-55.
-
8Nakashima M, Sonoda K, Watanabe K. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCASI[J]. Nat Med, 1999, 5(8): 938-942.
-
9Zaks TZ, Chappell DB, Rcsenberg SA, et al. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition[J]. J Immunol, 1999,162(6) :3273-3279.
-
10Real LM, Jimenez P, Kirkin A, et al. Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patlent[J]. Cancer Immunol Immunother,2001, 49(11):621-628.
同被引文献46
-
1王晓银,刘淑芸.妊娠与免疫耐受[J].国外医学(妇产科学分册),2004,31(3):144-148. 被引量:7
-
2温弘,谢幸,叶大风.肿瘤诱导树突状细胞凋亡研究进展[J].国外医学(肿瘤学分册),2004,31(9):662-664. 被引量:5
-
3Koji Yamaguchi,Munechika Enjoji,Manabu Nakashima,Makoto Nakamuta,Takashi Watanabe,Masao Tanaka.Novel serum tumor marker, RCASl, in pancreatic diseases[J].World Journal of Gastroenterology,2005,11(33):5199-5202. 被引量:12
-
4崔澂,王润田.参与肿瘤免疫逃逸的免疫抑制分子[J].临床肿瘤学杂志,2005,10(5):545-548. 被引量:8
-
5赵久达,耿排力.MICA基因研究进展及与疾病的关系[J].国外医学(遗传学分册),2005,28(5):317-320. 被引量:2
-
6崔永生,李欣,于春雷,辛精卫,李一,付彤.肺癌和乳腺癌患者外周血中CD4^+CD25^+T细胞及foxp3 mRNA的变化特点及临床意义[J].吉林大学学报(医学版),2006,32(5):843-846. 被引量:10
-
7徐林,蒋正刚,李宝华,熊思东.小鼠乳腺癌实验动物模型中CD4^+ CD25^+调节性T细胞的变化及意义[J].复旦学报(医学版),2006,33(6):736-740. 被引量:13
-
8邓敏,施勤,顾永平,谢芳,张学光.共刺激分子CD40在乳腺癌中的表达和生物学意义[J].江苏医药,2006,32(12):1160-1161. 被引量:2
-
9曹雪涛.肿瘤生长与转移中的免疫学问题[J].中国肿瘤生物治疗杂志,2007,14(1):2-6. 被引量:23
-
10高砚春,吴诚义.COX-2、VEGF-C在乳腺癌中的表达及与淋巴转移的关系[J].重庆医科大学学报,2007,32(9):915-918. 被引量:5
二级引证文献3
-
1张艳,叶克难.虫草灵芝孢子粉复合物对小鼠免疫功能的影响[J].食品科学,2012,33(17):269-273. 被引量:5
-
2李立,王亚东,王海玉,李江敏,张焱.灵芝洋参复合物对小鼠免疫功能的影响[J].中国卫生检验杂志,2019,29(24):2963-2965. 被引量:1
-
3兴伟,宋易华,徐曌,徐志峰,张欲翔,任伊宁.芪归八味饮联合化疗干预对乳腺癌术后气血两虚证患者免疫功能及生活质量的影响[J].河北中医,2022,44(2):248-252. 被引量:4
-
1姚鸿超,肖辉,王超,刘鸣,金德均.肿瘤坏死因子相关凋亡诱导配体诱导喉癌凋亡的实验研究[J].临床耳鼻咽喉头颈外科杂志,2011,25(3):127-129.
-
2姚根宏,侯亚义.肿瘤坏死因子相关凋亡配体抗肿瘤作用研究进展[J].卫生研究,2006,35(1):115-117. 被引量:5
-
3王亚军,李非,孙家邦.TRAIL在胰腺癌研究中的进展[J].中国现代普通外科进展,2004,7(4):198-200. 被引量:2
-
4贺占青,王立平,王凤安.Fas及其配体与胃癌的研究现状[J].华北国防医药,2002,14(1):31-33. 被引量:1
-
5陈洪卫,黄开华.CD_(47)-SIRPα通路在肿瘤免疫逃避和治疗中的应用[J].中国医药指南,2013,11(25):68-69. 被引量:1
-
6姚鸿超,肖辉,李茗华,王超,刘鸣.TRAIL联合多西紫杉醇对人鼻咽癌CNE2细胞的体外作用研究[J].现代生物医学进展,2010,10(6):1058-1060. 被引量:4
-
7周慧明,陈智,陈公英,李敏伟.TRAIL联合化疗药物诱导肝癌细胞凋亡的实验研究[J].中华肿瘤杂志,2003,25(2):152-153. 被引量:13
-
8林海,侯敢,黄迪南.以TRAIL为靶点的肿瘤治疗研究进展[J].生命科学,2007,19(5):492-495. 被引量:8
-
9关锋,龚平生,王志成,刘扬,龚守良.肿瘤坏死因子相关凋亡配体在肿瘤放射治疗中的作用[J].中华放射医学与防护杂志,2014,34(3):231-234. 被引量:3
-
10高宁,齐琳,齐范,曾庆富,蒋海鹰.Fas配体在膀胱癌中的表达及意义[J].中华泌尿外科杂志,2000,21(3):150-152. 被引量:2